Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03411070 · ClinicalTrials.gov registry record · Early Phase 1
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer
A Early Phase 1 study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 27
- Enrollment target
NCT03411070 is a Early Phase 1 study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 27 participants.
The verdict
NCT03411070, a Early Phase 1 study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This pilot clinical trial will evaluate whether the SCOUT reflector can be used to tag abnormal lymph nodes in patients with breast cancer prior to chemotherapy for targeted removal at the time of surgery. The SCOUT localization system with the SAVI reflector is non-radioactive and completely internal so can be placed into an abnormal lymph node prior to chemotherapy treatment, which theoretically will allow easier identification and therefore more reliable targeting of the abnormal lymph node for surgical removal.
Interventions
- PROCEDURE Therapeutic Conventional Surgery
- DEVICE Implanted Medical Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2019-04-07 |
| Est. Completion | 2021-12-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03411070
The ClinicalTrials.gov registry entry for NCT03411070 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Therapeutic Conventional Surgery is the first listed.
NCT03411070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03411070 about?
NCT03411070 is a clinical study titled "SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer". This pilot clinical trial will evaluate whether the SCOUT reflector can be used to tag abnormal lymph nodes in patients with breast cancer prior to chemotherapy for targeted removal at the time of surgery. The SCOUT localization system with the SAVI reflector is non-radioactive and completely intern...
What is the current status of trial NCT03411070?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 27 participants. The study started on 2019-04-07. Estimated completion is 2021-12-06.
What interventions are being tested in trial NCT03411070?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE), Implanted Medical Device (DEVICE).
Who is sponsoring clinical trial NCT03411070?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.